Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||- / 1||- / -|
Administered by: Other Purchased by: ??
Symptoms: Abortion spontaneous, Menstruation irregular, Vaginal haemorrhage, Off label use, Product use issue
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: FOLIC ACID; SERTRALINE
Current Illness: Breast feeding
Preexisting Conditions: Medical History/Concurrent Conditions: Anxiety; Miscarriage; Pregnancy (Patient no longer pregnant at the time of reporting.)
Diagnostic Lab Data:
CDC 'Split Type': GBPFIZER INC2021809656
Write-up: irregular periods; light spotting occured throughout early pregnancy; miscarriage/early miscarriage; ongoing breastfeeding, received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE); ongoing breastfeeding, received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE); This is a spontaneous report from a contactable consumer. This is a report received from the Regulatory Agency (RA). Regulatory authority report number [GB-MHRA-WEBCOVID-202106280819346800-ADNMT], Safety Report Unique Identifier [GB-MHRA-ADR 25553142]. A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 01Jun2021 as dose 1, single for COVID-19 immunisation. Medical history included abortion spontaneous from an unknown date and unknown if ongoing, pregnancy from an unknown date and unknown if ongoing (Patient no longer pregnant at the time of reporting), ongoing breast feeding and anxiety from an unknown date and unknown if ongoing. Concomitant medications included folic acid (Manufacture Unknown) taken for an unspecified indication, start and stop date were not reported; sertraline (Manufacture Unknown) taken for anxiety state, start and stop date were not reported. On an unspecified date, the patient experienced irregular periods, light spotting occured throughout early pregnancy, miscarriage/early miscarriage. The outcome of the event ''miscarriage/early miscarriage'' was recovering. The outcome of the events ''irregular periods'' and ''light spotting occured throughout early pregnancy'' was recovered on an unspecified date. The clinical course was reported as follows: Vaccine given on 01Jun2021 around the time of conception. Light spotting occurred throughout early pregnancy, then a full miscarriage 3-4 weeks later. Possibly completely unrelated but the patient saw a lot of people reporting heavier or irregular periods after the vaccine so wondered if the vaccine and miscarriage could be connected. Patient has not tested positive for COVID-19 since having the vaccine. Additional information: Unsure if the medicine has an adverse effect on any aspect of the pregnancy. Patient did not take folic acid supplement during pregnancy. Patient was exposed to the medicine first-trimester (1-12 weeks). No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166